everolimus

PRINCETON, N.J. — September 23, 2026 ANI Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted...

Agoura Hills, Calif., July 22, 2026 Oncotelic Therapeutics and Sapu Nano announced the publication of a peer-reviewed study in...

Basel, Switzerland — September 22, 2025 — Positive phase III trial results from the evERA study reveal that the...